MCUJF
Price
$0.71
Change
-$0.06 (-7.79%)
Updated
Aug 27 closing price
Capitalization
8.46M
MEDIF
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Sep 5 closing price
Capitalization
22.84M
Interact to see
Advertisement

MCUJF vs MEDIF

Header iconMCUJF vs MEDIF Comparison
Open Charts MCUJF vs MEDIFBanner chart's image
Medicure
Price$0.71
Change-$0.06 (-7.79%)
Volume$5K
Capitalization8.46M
Medipharm Labs
Price$0.05
Change-$0.00 (-0.00%)
Volume$48.26K
Capitalization22.84M
MCUJF vs MEDIF Comparison Chart in %
Loading...
MCUJF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MEDIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MCUJF vs. MEDIF commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MCUJF is a Hold and MEDIF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (MCUJF: $0.71 vs. MEDIF: $0.05)
Brand notoriety: MCUJF and MEDIF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: MCUJF: 317% vs. MEDIF: 40%
Market capitalization -- MCUJF: $8.46M vs. MEDIF: $22.84M
MCUJF [@Pharmaceuticals: Generic] is valued at $8.46M. MEDIF’s [@Pharmaceuticals: Generic] market capitalization is $22.84M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MCUJF’s FA Score shows that 1 FA rating(s) are green whileMEDIF’s FA Score has 0 green FA rating(s).

  • MCUJF’s FA Score: 1 green, 4 red.
  • MEDIF’s FA Score: 0 green, 5 red.
According to our system of comparison, MCUJF is a better buy in the long-term than MEDIF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MCUJF’s TA Score shows that 4 TA indicator(s) are bullish while MEDIF’s TA Score has 3 bullish TA indicator(s).

  • MCUJF’s TA Score: 4 bullish, 4 bearish.
  • MEDIF’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, MCUJF is a better buy in the short-term than MEDIF.

Price Growth

MCUJF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while MEDIF (@Pharmaceuticals: Generic) price change was -9.19% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.09%. For the same industry, the average monthly price growth was +9.01%, and the average quarterly price growth was +87.13%.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.09% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MEDIF($22.8M) has a higher market cap than MCUJF($8.46M). MEDIF YTD gains are higher at: 25.327 vs. MCUJF (13.790). MCUJF has higher annual earnings (EBITDA): 951K vs. MEDIF (-4.75M). MEDIF has more cash in the bank: 8.44M vs. MCUJF (7.22M). MEDIF has less debt than MCUJF: MEDIF (125K) vs MCUJF (876K). MEDIF has higher revenues than MCUJF: MEDIF (43M) vs MCUJF (21.7M).
MCUJFMEDIFMCUJF / MEDIF
Capitalization8.46M22.8M37%
EBITDA951K-4.75M-20%
Gain YTD13.79025.32754%
P/E Ratio11.51N/A-
Revenue21.7M43M50%
Total Cash7.22M8.44M85%
Total Debt876K125K701%
FUNDAMENTALS RATINGS
MCUJF vs MEDIF: Fundamental Ratings
MCUJF
MEDIF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
91
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9595
PRICE GROWTH RATING
1..100
6459
P/E GROWTH RATING
1..100
26100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MCUJF's Valuation (63) in the null industry is in the same range as MEDIF (91). This means that MCUJF’s stock grew similarly to MEDIF’s over the last 12 months.

MCUJF's Profit vs Risk Rating (100) in the null industry is in the same range as MEDIF (100). This means that MCUJF’s stock grew similarly to MEDIF’s over the last 12 months.

MCUJF's SMR Rating (95) in the null industry is in the same range as MEDIF (95). This means that MCUJF’s stock grew similarly to MEDIF’s over the last 12 months.

MEDIF's Price Growth Rating (59) in the null industry is in the same range as MCUJF (64). This means that MEDIF’s stock grew similarly to MCUJF’s over the last 12 months.

MCUJF's P/E Growth Rating (26) in the null industry is significantly better than the same rating for MEDIF (100). This means that MCUJF’s stock grew significantly faster than MEDIF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MCUJFMEDIF
RSI
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
70%
Bullish Trend 4 days ago
86%
Momentum
ODDS (%)
Bearish Trend 4 days ago
78%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
62%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
72%
Bullish Trend 4 days ago
87%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
89%
Aroon
ODDS (%)
Bullish Trend 4 days ago
68%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
MCUJF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MEDIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FMFP11.35N/A
N/A
First Community Financial Corp.
TATYF7.25N/A
N/A
Tate & Lyle, PLC
UPMKF28.45N/A
N/A
UPM-Kymmene Corp.
WKGFF0.05N/A
N/A
Westkam Gold Corp.
ELLRY2.40N/A
N/A
Elringklinger Ag

MCUJF and

Correlation & Price change

A.I.dvisor tells us that MCUJF and LVRLF have been poorly correlated (+18% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MCUJF and LVRLF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MCUJF
1D Price
Change %
MCUJF100%
N/A
LVRLF - MCUJF
18%
Poorly correlated
+1.96%
MVMDF - MCUJF
11%
Poorly correlated
-9.82%
JUSHF - MCUJF
7%
Poorly correlated
+6.59%
MEDXF - MCUJF
4%
Poorly correlated
N/A
MEDIF - MCUJF
1%
Poorly correlated
-1.26%
More

MEDIF and

Correlation & Price change

A.I.dvisor tells us that MEDIF and SWGHF have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MEDIF and SWGHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MEDIF
1D Price
Change %
MEDIF100%
-1.26%
SWGHF - MEDIF
29%
Poorly correlated
N/A
GLASF - MEDIF
25%
Poorly correlated
+3.99%
AAWH - MEDIF
23%
Poorly correlated
+6.62%
TCNNF - MEDIF
22%
Poorly correlated
+4.55%
CURLF - MEDIF
22%
Poorly correlated
+1.79%
More